[1] Mohlin C, et al. Studies of the extracellular ATP-adenosine pathway in human urinary tract epithelial cells. Pharmacology. 2009;84(4):196-202. DOI:
10.1159/000235908[2] BRUNS R F. Adenosine receptor activation by adenine nucleotides requires conversion of the nucleotides to adenosine.[J]. Naunyn-Schmiedeberg’s archives of pharmacology, 1980, 315 1: 5-13. DOI:
10.1007/bf00504224[3] ELIZANDRA BRAGANHOL . Ecto-5′-nucleotidase/CD73 inhibition by quercetin in the human U138MG glioma cell line[J]. Biochimica et biophysica acta. General subjects, 2007, 1770 9: Pages 1352-1359. DOI:
10.1016/j.bbagen.2007.06.003[4] SHALAIMAITI SHALI. Ecto-5′-nucleotidase (CD73) is a potential target of hepatocellular carcinoma[J]. Journal of Cellular Physiology, 2018, 234 7: 10248-10259. DOI:
10.1002/jcp.27694[5] GIOVANNI FORTE. Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma.[J]. Journal of immunology, 2012, 189 5: 2226-2233. DOI:
10.4049/jimmunol.1200744
